Chase Science Co., Ltd (SHE:300941)
China · Delayed Price · Currency is CNY 15.08
-0.21 (-1.37%)
At close: Sep 10, 2026
Chase Science Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 260.88 | 246.62 | 209.36 | 261.25 | 395.16 | 420.37 |
Revenue Growth | 28.67% | 17.80% | -19.86% | -33.89% | -6.00% | -31.52% |
Gross Profit Gross Profit Growth | 96.58 | 92.15 | 105.71 | 142.7 | 176.43 | 174.06 |
Operating Income Operating Income Growth | 4.98 | 6.66 | 13.21 | 49.4 | 82.51 | 85.66 |
Net Income Net Income Growth | 23.32 | 32.76 | 55.61 | 81.27 | 110.52 | 106.03 |
Earnings Per Share EPS Growth | 0.24 | 0.16 | 0.27 | 0.40 | 0.54 | 0.52 |
EPS Growth | 11.65% | -40.74% | -32.50% | -25.93% | 3.85% | -45.44% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 676.02 | 1,163 | 1,139 | 1,168 | 1,226 | 1,158 |
Total Debt Total Debt Growth | 3.16 | 2.2 | 3.74 | 4.76 | 3.78 | 4.86 |
Net Cash (Debt) Net Cash Growth | 672.85 | 1,161 | 1,135 | 1,164 | 1,222 | 1,153 |
Net Cash Growth | -34.05% | 2.27% | -2.42% | -4.82% | 6.05% | 174.23% |
Net Cash Per Share Net Cash Per Share Growth | 6.81 | 5.67 | 5.51 | 5.73 | 5.97 | 5.65 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -31.11 | -23.52 | 15.84 | -0.88 | 90.26 | 102.41 |
Capital Expenditures CapEx Growth | -0.22 | -0.49 | -1.05 | -1.13 | -1.63 | -1.38 |
Free Cash Flow Free Cash Flow Growth | -31.33 | -24 | 14.79 | -2.01 | 88.63 | 101.03 |
Free Cash Flow Growth | - | - | - | - | -12.27% | -34.70% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 37.02% | 37.36% | 50.49% | 54.62% | 44.65% | 41.41% |
Operating Margin | 1.91% | 2.70% | 6.31% | 18.91% | 20.88% | 20.38% |
Pretax Margin | 9.70% | 15.68% | 26.81% | 34.36% | 30.47% | 28.05% |
Profit Margin | 8.94% | 13.29% | 26.56% | 31.11% | 27.97% | 25.22% |
FCF Margin | -12.01% | -9.73% | 7.07% | -0.77% | 22.43% | 24.03% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.082 | 0.082 | 0.140 | 0.140 | 0.170 | 0.153 |
Dividend Per Share Growth | -41.43% | -41.43% | 0% | -17.65% | 10.89% | -23.35% |
Dividend Yield | 0.53% | 0.35% | 0.47% | 0.59% | 0.92% | 0.47% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 64.82 | 146.26 | 110.59 | 60.90 | 35.31 | 65.75 |
P/FCF Ratio | - | - | 415.72 | - | 44.03 | 69.00 |
PS Ratio | 11.90 | 19.43 | 29.37 | 18.95 | 9.88 | 16.58 |